110 related articles for article (PubMed ID: 7840794)
21. Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia.
Schimmel KJ; Nijmeijer BA; van Schie ML; Falkenburg JH; Guchelaar HJ
Leuk Res; 2007 Nov; 31(11):1545-51. PubMed ID: 17459472
[TBL] [Abstract][Full Text] [Related]
22. Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.
Van Bree C; Barten-Van Rijbroek AD; Leen R; Rodermond HM; Van Kuilenburg AB; Kal HB
Int J Oncol; 2009 Mar; 34(3):813-9. PubMed ID: 19212686
[TBL] [Abstract][Full Text] [Related]
23. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
Bierau J; Van Gennip AH; Leen R; Helleman J; Caron HN; Van Kuilenburg AB
Int J Cancer; 2003 Jan; 103(3):387-92. PubMed ID: 12471622
[TBL] [Abstract][Full Text] [Related]
24. Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.
van Bree C; Rodermond H; Leen R; Medema J; van Kuilenburg A
Br J Cancer; 2008 Apr; 98(7):1226-33. PubMed ID: 18349845
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
Yee LK; Allegra CJ; Trepel JB; Grem JL
Biochem Pharmacol; 1992 Apr; 43(7):1587-99. PubMed ID: 1567480
[TBL] [Abstract][Full Text] [Related]
26. A single point mutation in CTP synthetase of Chlamydia trachomatis confers resistance to cyclopentenyl cytosine.
Wylie JL; Wang LL; Tipples G; McClarty G
J Biol Chem; 1996 Jun; 271(26):15393-400. PubMed ID: 8663065
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the experimental cytotoxic drug cyclopentenyl cytosine and its metabolite in plasma with HPLC tandem mass spectrometry.
Schimmel K; van Lenthe H; Leen R; Kulik W; Verschuur A; Guchelaar HJ; van Kuilenburg A
Biomed Chromatogr; 2008 Dec; 22(12):1368-73. PubMed ID: 18661479
[TBL] [Abstract][Full Text] [Related]
28. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Huang M; Whang P; Lewicki P; Mitchell BS
Mol Pharmacol; 2011 Jul; 80(1):40-8. PubMed ID: 21464199
[TBL] [Abstract][Full Text] [Related]
29. Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo.
Gharehbaghi K; Szekeres T; Yalowitz JA; Fritzer-Szekeres M; Pommier YG; Jayaram HN
Life Sci; 2000 Nov; 68(1):1-11. PubMed ID: 11132239
[TBL] [Abstract][Full Text] [Related]
30. Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats.
Schimmel K; Bennink R; de Bruin K; Leen R; Sand K; van den Hoff M; van Kuilenburg A; Vanderheyden JL; Steinmetz N; Pfaffendorf M; Verschuur A; Guchelaar HJ
Arch Toxicol; 2005 May; 79(5):268-76. PubMed ID: 15902424
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
32. The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytes.
Nikolaeva N; Bemelman FJ; Yong SL; Verschuur A; van Lier RA; ten Berge IJ
Clin Exp Immunol; 2008 Feb; 151(2):348-58. PubMed ID: 18062797
[TBL] [Abstract][Full Text] [Related]
33. Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?
van Bree C; van Kuilenburg AB
Leuk Res; 2008 Feb; 32(2):201-2. PubMed ID: 17681375
[No Abstract] [Full Text] [Related]
34. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells.
Glazer RI; Knode MC; Lim MI; Marquez VE
Biochem Pharmacol; 1985 Jul; 34(14):2535-9. PubMed ID: 4015694
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine.
Copp RR; Marquez VE
J Med Chem; 1991 Jan; 34(1):208-12. PubMed ID: 1992119
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1994 Apr; 5(2):223-8. PubMed ID: 7519483
[TBL] [Abstract][Full Text] [Related]
38. Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine.
Verschuur AC; Van Gennip AH; Leen R; Van Kuilenburg AB
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1517-21. PubMed ID: 15571289
[TBL] [Abstract][Full Text] [Related]
39. Recovery of SK-N-BE(2)c cells from treatment with cyclopentenyl cytosine.
Bierau J; van Gennip AH; van Kuilenburg AB
Adv Exp Med Biol; 2000; 486():277-80. PubMed ID: 11783499
[No Abstract] [Full Text] [Related]
40. Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).
Peters GJ; Smid K; Vecchi L; Kathmann I; Sarkisjan D; Honeywell RJ; Losekoot N; Ohne O; Orbach A; Blaugrund E; Jeong LS; Lee YB; Ahn CH; Kim DJ
Invest New Drugs; 2013 Dec; 31(6):1444-57. PubMed ID: 24048768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]